Health Economics and Policy

Thanks to European approval of a new indication for Lucentis, preterm infants with ROP finally have a pharmacotherapeutic option

Drugs used to treat retinal disorders appear to pass into breast milk, posing a potential risk to the normal development of nursing infants

Three diabetic eye disease gurus discuss prevention, detection, diagnosis, and treatment – and explain why it’s important to consider the future

AI image interpretation will not solve the diabetic retinopathy epidemic

Aflibercept’s newly approved administration regime permits a reduction in intravitreal injection frequency

NICE offers new option for retinal dystrophy patients

Shared ophthalmic care is needed, but patients’ interests must always come before politics

An entwined image of ophthalmologists and optometrists: the front line of eye care

Ahead of the Ophthalmology Innovation Summit 2019 at AAO, we reach out to a panel of experts to uncover market trends

The remit of ophthalmologists and optometrists is not set in stone, it must evolve over time